Effectiveness–implementation hybrid-2 randomised trial of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children (DAISY): pilot study protocol
Introduction In Australia, while paediatric intensive care unit (PICU) mortality has dropped to 2.2%, one in three survivors experience long-term neurodevelopmental impairment, limiting their life-course opportunities. Unlike other high-risk paediatric populations, standardised routine neurodevelopm...
Saved in:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-07-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/7/e060714.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832576158136270848 |
---|---|
author | Paula Lister Kristen Gibbons Zephanie Tyack Luregn J Schlapbach Samudragupta Bora Maria Isabel Castillo James Best Debbie Long Helen G Liley Belinda Dow Kerri-Lyn Webb Christian Stocker Debra Thoms Carolyn Wharton Lori Matuschka |
author_facet | Paula Lister Kristen Gibbons Zephanie Tyack Luregn J Schlapbach Samudragupta Bora Maria Isabel Castillo James Best Debbie Long Helen G Liley Belinda Dow Kerri-Lyn Webb Christian Stocker Debra Thoms Carolyn Wharton Lori Matuschka |
author_sort | Paula Lister |
collection | DOAJ |
description | Introduction In Australia, while paediatric intensive care unit (PICU) mortality has dropped to 2.2%, one in three survivors experience long-term neurodevelopmental impairment, limiting their life-course opportunities. Unlike other high-risk paediatric populations, standardised routine neurodevelopmental follow-up of PICU survivors is rare, and there is limited knowledge regarding the best methods. The present study intends to pilot a combined multidisciplinary, online screening platform and general practitioner (GP) shared care neurodevelopmental follow-up model to determine feasibility of a larger, future study. We will also assess the difference between neurodevelopmental vulnerability and parental stress in two intervention groups and the impact of child, parent, sociodemographic and illness/treatment risk factors on child and parent outcomes.Methods and analysis Single-centre randomised effectiveness–implementation (hybrid-2 design) pilot trial for parents of children aged ≥2 months and <4 years discharged from PICU after critical illness or injury. One intervention group will receive 6 months of collaborative shared care follow-up with GPs (supported by online outcome monitoring), and the other will be offered self-directed screening and education about post-intensive care syndrome and child development. Participants will be followed up at 1, 3 and 6 months post-PICU discharge. The primary outcome is feasibility. Secondary outcomes include neurodevelopmental vulnerability and parental stress. An implementation evaluation will analyse barriers to and facilitators of the intervention.Ethics and dissemination The study is expected to lead to a full trial, which will provide much-needed guidance about the clinical effectiveness and implementation of follow-up models of care for children after critical illness or injury. The Children’s Health Queensland Human Research Ethics Committee approved this study. Dissemination of the outcomes of the study is expected via publication in a peer-reviewed journal, presentation at relevant conferences, and via social media, podcast presentations and open-access medical education resources.Registration details The trial was prospectively registered with the Australian New Zealand Clinical Trials Registry as ‘Pilot testing of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children’ (the DAISY Pilot Study).Trial registration number ACTRN12621000799853. |
format | Article |
id | doaj-art-d081719c5ef744a8872f1bd3339a34e2 |
institution | Kabale University |
issn | 2044-6055 |
language | English |
publishDate | 2022-07-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | BMJ Open |
spelling | doaj-art-d081719c5ef744a8872f1bd3339a34e22025-01-31T10:50:10ZengBMJ Publishing GroupBMJ Open2044-60552022-07-0112710.1136/bmjopen-2021-060714Effectiveness–implementation hybrid-2 randomised trial of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children (DAISY): pilot study protocolPaula Lister0Kristen Gibbons1Zephanie Tyack2Luregn J Schlapbach3Samudragupta Bora4Maria Isabel Castillo5James Best6Debbie Long7Helen G Liley8Belinda Dow9Kerri-Lyn Webb10Christian Stocker11Debra Thoms12Carolyn Wharton13Lori Matuschka14Paediatric Critical Care Unit, Sunshine Coast University Hospital, Sunshine Coast, Queensland, AustraliaChild Health Research Centre, The University of Queensland, Brisbane, Queensland, AustraliaCentre for Children’s Burns and Trauma Research, University of Queensland, South Brisbane, Queensland, AustraliaDepartment of Intensive Care and Neonatology and Children`s Research Center, University Children`s Hospital Zürich, Zurich, SwitzerlandMothers, Babies and Women’s Health Program, Mater Research Institute, Faculty of Medicine, The University of Queensland, South Brisbane, Queensland, AustraliaSchool of Nursing, Queensland University of Technology, Brisbane, Queensland, AustraliaGeneral Practice, Junction Street Family Practice, Nowra, New South Wales, AustraliaPaediatric Intensive Care Unit, Queensland Children`s Hospital, South Brisbane, Queensland, AustraliaMater Research Institute, The University of Queensland, South Brisbane, Queensland, AustraliaSchool of Nursing, Queensland University of Technology, Brisbane, Queensland, AustraliaDevelopmental Paediatrics, Children`s Health Queensland Hospital and Health Service, South Brisbane, Queensland, AustraliaPaediatric Intensive Care Unit, Queensland Children`s Hospital, South Brisbane, Queensland, AustraliaSchool of Nursing, Queensland University of Technology, Brisbane, Queensland, AustraliaConsumer Representative, Health Consumers Queensland, Brisbane, Queensland, AustraliaSchool of Nursing, Queensland University of Technology, Brisbane, Queensland, AustraliaIntroduction In Australia, while paediatric intensive care unit (PICU) mortality has dropped to 2.2%, one in three survivors experience long-term neurodevelopmental impairment, limiting their life-course opportunities. Unlike other high-risk paediatric populations, standardised routine neurodevelopmental follow-up of PICU survivors is rare, and there is limited knowledge regarding the best methods. The present study intends to pilot a combined multidisciplinary, online screening platform and general practitioner (GP) shared care neurodevelopmental follow-up model to determine feasibility of a larger, future study. We will also assess the difference between neurodevelopmental vulnerability and parental stress in two intervention groups and the impact of child, parent, sociodemographic and illness/treatment risk factors on child and parent outcomes.Methods and analysis Single-centre randomised effectiveness–implementation (hybrid-2 design) pilot trial for parents of children aged ≥2 months and <4 years discharged from PICU after critical illness or injury. One intervention group will receive 6 months of collaborative shared care follow-up with GPs (supported by online outcome monitoring), and the other will be offered self-directed screening and education about post-intensive care syndrome and child development. Participants will be followed up at 1, 3 and 6 months post-PICU discharge. The primary outcome is feasibility. Secondary outcomes include neurodevelopmental vulnerability and parental stress. An implementation evaluation will analyse barriers to and facilitators of the intervention.Ethics and dissemination The study is expected to lead to a full trial, which will provide much-needed guidance about the clinical effectiveness and implementation of follow-up models of care for children after critical illness or injury. The Children’s Health Queensland Human Research Ethics Committee approved this study. Dissemination of the outcomes of the study is expected via publication in a peer-reviewed journal, presentation at relevant conferences, and via social media, podcast presentations and open-access medical education resources.Registration details The trial was prospectively registered with the Australian New Zealand Clinical Trials Registry as ‘Pilot testing of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children’ (the DAISY Pilot Study).Trial registration number ACTRN12621000799853.https://bmjopen.bmj.com/content/12/7/e060714.full |
spellingShingle | Paula Lister Kristen Gibbons Zephanie Tyack Luregn J Schlapbach Samudragupta Bora Maria Isabel Castillo James Best Debbie Long Helen G Liley Belinda Dow Kerri-Lyn Webb Christian Stocker Debra Thoms Carolyn Wharton Lori Matuschka Effectiveness–implementation hybrid-2 randomised trial of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children (DAISY): pilot study protocol BMJ Open |
title | Effectiveness–implementation hybrid-2 randomised trial of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children (DAISY): pilot study protocol |
title_full | Effectiveness–implementation hybrid-2 randomised trial of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children (DAISY): pilot study protocol |
title_fullStr | Effectiveness–implementation hybrid-2 randomised trial of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children (DAISY): pilot study protocol |
title_full_unstemmed | Effectiveness–implementation hybrid-2 randomised trial of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children (DAISY): pilot study protocol |
title_short | Effectiveness–implementation hybrid-2 randomised trial of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children (DAISY): pilot study protocol |
title_sort | effectiveness implementation hybrid 2 randomised trial of a collaborative shared care model for detecting neurodevelopmental impairments after critical illness in young children daisy pilot study protocol |
url | https://bmjopen.bmj.com/content/12/7/e060714.full |
work_keys_str_mv | AT paulalister effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol AT kristengibbons effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol AT zephanietyack effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol AT luregnjschlapbach effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol AT samudraguptabora effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol AT mariaisabelcastillo effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol AT jamesbest effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol AT debbielong effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol AT helengliley effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol AT belindadow effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol AT kerrilynwebb effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol AT christianstocker effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol AT debrathoms effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol AT carolynwharton effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol AT lorimatuschka effectivenessimplementationhybrid2randomisedtrialofacollaborativesharedcaremodelfordetectingneurodevelopmentalimpairmentsaftercriticalillnessinyoungchildrendaisypilotstudyprotocol |